Accure Therapeutics

iQure Pharma

This clinical-stage biotech company develops astrocyte-targeted therapeutics to restore glutamate balance for patients with central nervous system disorders such as epilepsy and Parkinson's disease.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Pheno Therapeutics

This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.

Progentos Therapeutics

The company develops small-molecule drugs to regenerate myelin for the treatment of patients with multiple sclerosis.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

Cerevel Therapeutics

This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.